Insider · CIK 0001908125
Stanley Tyler Hollmig
Files at VERO (Venus Concept Inc.). First filing Nov 22, 2022, latest Nov 22, 2022.
In brief
Stanley Tyler Hollmig files SEC Form 4 as director at VERO (Venus Concept Inc.). Since Nov 22, 2022, Stanley Tyler Hollmig has reported 1 open-market buy worth $50k and 0 open-market sells worth $0, the latest filed on Nov 22, 2022.
A track record needs three past buys with six months of prices behind them; Stanley Tyler Hollmig has 0, so none is measured yet.
The newest scored trade: bought $50k of VERO on Nov 18, 2022, filed Nov 22, 2022, scored 47 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | Venus Concept Inc. | $50k 250,000 shares | +625% | - |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | VERO Venus Concept Inc. | POpen-market purchase Common Stock | +250,000 | $0.20 | $50k | 290,000 | Nov 22, 2022 |
Questions about Stanley Tyler Hollmig
Answered from the filings on this page, as of the latest one.
Is Stanley Tyler Hollmig buying or selling?
Not in the last 12 months. Stanley Tyler Hollmig's latest open-market trade on SEC Form 4 was bought $50k of VERO on Nov 18, 2022.
How did Stanley Tyler Hollmig's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stanley Tyler Hollmig has 0.
Where does Stanley Tyler Hollmig file Form 4?
Stanley Tyler Hollmig has filed Form 4 at VERO (Venus Concept Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.